Global Artificial Saliva Market Is Anticipated to Surge Approximately $11.5 Billion By 2030

The global artificial saliva industry size was nearly $8.7 Billion in 2022 and is anticipated to surge to approximately $11.5 Billion by 2030 along with recording the highest growth rate of nearly 9.6% from 2023 to 2030.

Artificial saliva is utilized for treating xerostomia. Furthermore, artificial saliva helps by moisturizing desiccated oral tissues. Apart from this, the physical & biological characteristics of artificial saliva are the same as that of normal human saliva. In addition to this, the former is an integration of buffering agents, flavoring agents, and cellulose derivatives. Saliva replacement can be accessed as a spectrum of agents such as gels, mouthwash, liquids, sprays, mouthwash, oils, toothpaste, and chewing gums.

High spending on oral care products will steer the growth of the global artificial saliva market over the forthcoming years. As per the World Health Organization, oral disorders are the fourth most costly ailments to treat across emerging as well as developed countries. Rise in cases of cancer leading to chemotherapy has led to the occurrence of dry mouth, thereby prompting the global market growth trends. The utilization of artificial saliva assists in the prevention of dysphagia and this has led to massive expansion of the global market. Humongous popularity of oral sprays, oral gels, and oral liquids in dentistry has bolstered the growth of the global market. Huge per capita spending on oral care products is likely to accelerate the growth of the market across the globe.

Nevertheless, the easy availability of apt alternative products for treating dry mouth can put brakes on the growth of the artificial saliva industry globally. However, escalating demand for minimizing the proliferation of microbes in the mouth along with the need for preventing infection of oral cavities can generate new vistas of growth for the global artificial saliva industry.

The global artificial saliva market is divided into product, age group, distribution channel, and region.            

The product segment of the artificial saliva market is sub-segmented into oral sprays, gels, oral liquids, oral solutions, and powders segments. Furthermore, the oral sprays segment, which accounted for more than 33% of the global artificial saliva market revenue in 2022, is slated to retain its dominant status in the forecasting timeline. The segmental surge in the coming years can be credited to the growing demand for these products by customers due to its user-friendly characteristics. Apart from this, oral sprays are cost-effective and are easily available as a physician’s prescription is not required for its purchase.

On the basis of distribution channel, the artificial saliva industry across the globe is divided into supermarkets & hypermarkets, mail order pharmacies, retail pharmacies, and hospital pharmacies segments. The mail order pharmacies segment, which led the distribution channel segment in 2022, is set to contribute a major share of the global industry in the upcoming years. The growth of the segment in the ensuing timeline can be due to easy access to artificial saliva products in mail order pharmacies. In addition to this, mail order pharmacies provide large-scale advantages including discount offers, personal customer service, and easy medicine refilling.

On the basis of age group, the global artificial saliva market is sectored into adults and pediatric segments.

Furthermore, North America, which accounted for a major revenue share of the global artificial saliva market in 2022, is projected to lead the regional market growth over the forecast timespan. The regional market surge over 2023-2030 can be due to easy access to strong healthcare infrastructure and the availability of innovative artificial saliva products. In addition to this, the rise in the spending capacity of customers in countries such as the U.S. and Canada will expand the scope of the regional market expansion. Surge in the frequency of Sjogren’s syndrome witnessed in the countries such as the U.S. will set a strong podium for the growth of the market in North America in the years ahead.

This review is based on a report by Zion Market Research, titled “Artificial Saliva Market By Product (Oral Sprays, Oral Liquids, Oral Solutions, Gels, and Powders), By Age-Group (Adults and Pediatric), By Distribution Channel (Supermarkets & Hypermarkets, Retail Pharmacies, Mail Order Pharmacies, and Hospital Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030.”- Report at https://www.zionmarketresearch.com/report/artificial-saliva-market

Recent Developments:

• In the first half of 2021, Parnell Pharmaceuticals, Inc., a key pharmaceutical company, launched Mouth Kote-MD, an oral spray based on the concept of MycoDelens coined by New York Tech University. The initiative is likely to boost the growth of the global artificial saliva industry across the globe.
• In the first quarter of 2023, HempStreet, an Indian medicinal cannabis company, entered into collaboration with MGC Pharmaceuticals Ltd, a European bio-based pharma company, for launching ArtemiC, a nutraceutical mouth spray, for assisting patients to recover from severe COVID-19 symptoms. The move will provide impetus to the expansion of the artificial saliva market in India.
• In the first half of 2023, Arlak Biotech, a key pharmaceutical company based in India, introduced Arlak Melatonin Spray for enhancing the body’s melatonin production for improving sleep for people affected by insomnia. The initiative will account majorly toward the expansion of the artificial saliva market in India.

Key players in the global artificial saliva market include:

• Biocosmetics Laboratories
• Bausch Health Companies Inc.
• CCMed Ltd
• Cipla Ltd.
• Forward Science
• ICPA Health Pvt. Ltd.
• Fresenius Kabi AG
• Mission Pharmacal Company
• Perrigo Company PLC
• GlaxoSmithKline PLC
• Midatech Pharma PLC
• Laboratorios Kin S.A.

The global artificial saliva market is segmented as follows:

By Product

• Oral Sprays
• Oral Liquids
• Oral Solutions
• Gels
• Powders

By Age-Group

• Adults
• Pediatric

By Distribution channel

• Supermarkets & Hypermarkets
• Retail Pharmacies
• Mail Order Pharmacies
• Hospital Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com